References
- Yancy C.W.
- Jessup M.
- Bozkurt B.
- et al.
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013; 62: e147-e239View in Article- Scopus (4706)
- PubMed
- Crossref
- Google Scholar
- Peacock W.F.
- Cannon C.M.
- Singer A.J.
- et al.
Considerations for initial therapy in the treatment of acute heart failure. 2015; 19: 399View in Article- Scopus (14)
- PubMed
- Crossref
- Google Scholar
- Fonarow G.C.
- Stough W.G.
- Abraham W.T.
- et al.
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. 2007; 50: 768-777View in Article- Scopus (824)
- PubMed
- Crossref
- Google Scholar
- Peacock F.
- Amin A.
- Granger C.B.
- et al.
Hypertensive heart failure: patient characteristics, treatment, and outcomes. 2011; 29: 855-862View in Article- Scopus (33)
- PubMed
- Abstract
- Full Text
- Full Text PDF
- Google Scholar
- Cotter G.
- Metra M.
- Milo-Cotter O.
- et al.
Fluid overload in acute heart failure–re-distribution and other mechanisms beyond fluid accumulation. 2008; 10: 165-169View in Article- Scopus (234)
- PubMed
- Crossref
- Google Scholar
- Viau D.M.
- Sala-Mercado J.A.
- Spranger M.D.
- et al.
The pathophysiology of hypertensive acute heart failure. 2015; 101: 1861-1867View in Article- Scopus (38)
- PubMed
- Crossref
- Google Scholar
- Adams Jr., K.F.
- Fonarow G.C.
- Emerman C.L.
- et al.
Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). 2005; 149: 209-216View in Article- Scopus (1653)
- PubMed
- Crossref
- Google Scholar
- Arterial stiffness and vascular load in heart failure. 2008; 14: 31-36View in Article
- Scopus (56)
- PubMed
- Crossref
- Google Scholar
- Ventricular-vascular interaction in heart failure. 2008; 4: 23-36View in Article
- Scopus (229)
- PubMed
- Abstract
- Full Text
- Full Text PDF
- Google Scholar
- Arterial aging: pathophysiological principles. 2007; 12: 329-341View in Article
- Gheorghiade M.
- Filippatos G.
- De Luca L.
- et al.
Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. 2006; 119 (S3–s10)View in Article- Braunwald’s heart disease: a textbook of cardiovascular medicine, 2-Volume Set – 9780323463423 | US Elsevier Health Bookshop. Elsevier. (Available at:)https://www.us.elsevierhealth.com/braunwalds-heart-disease-a-textbook-of-cardiovascular-medicine-2-volume-set-9780323463423.html (Accessed February 1, 2018)View in Article
- Acute heart failure syndromes. 2009; 53: 557-573View in Article
- Scopus (462)
- PubMed
- Crossref
- Google Scholar
- Yancy C.W.
- Jessup M.
- Bozkurt B.
- et al.
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. 2013; 128: 1810-1852View in Article- Scopus (1646)
- PubMed
- Crossref
- Google Scholar
- Peacock W.F.
- Fonarow G.C.
- Emerman C.L.
- et al.
Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. 2007; 107: 44-51View in Article- Scopus (86)
- PubMed
- Crossref
- Google Scholar
- Catecholamine-induced changes in the splanchnic circulation affecting systemic hemodynamics. 2004; 100: 434-439View in Article
- Scopus (133)
- PubMed
- Crossref
- Google Scholar
- Gandhi S.K.
- Powers J.C.
- Nomeir A.M.
- et al.
The pathogenesis of acute pulmonary edema associated with hypertension. 2001; 344: 17-22View in Article- Scopus (629)
- PubMed
- Crossref
- Google Scholar
- Schreiber W.
- Woisetschläger C.
- Binder M.
- et al.
The nitura study–effect of nitroglycerin or urapidil on hemodynamic, metabolic and respiratory parameters in hypertensive patients with pulmonary edema. 1998; 24: 557-563View in Article- Jhund P.S.
- McMurray J.J.
- Davie A.P.
The acute vascular effects of frusemide in heart failure. 2000; 50: 9-13View in Article- Dikshit K.
- Vyden J.K.
- Forrester J.S.
- et al.
Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. 1973; 288: 1087-1090View in Article- Scopus (401)
- PubMed
- Crossref
- Google Scholar
- Franciosa J.A.
- Silverstein S.R.
Hemodynamic effects of nitroprusside and furosemide in left ventricular failure. 1982; 32: 62-69View in Article- Pickkers P.
- Dormans T.P.
- Russel F.G.
- et al.
Direct vascular effects of furosemide in humans. 1997; 96: 1847-1852View in Article- Holzer-Richling N.
- Holzer M.
- Herkner H.
- et al.
Randomized placebo controlled trial of furosemide on subjective perception of dyspnoea in patients with pulmonary oedema because of hypertensive crisis. 2011; 41: 627-634View in Article- Butler J.
- Forman D.E.
- Abraham W.T.
- et al.
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. 2004; 147: 331-338View in Article- Scopus (417)
- PubMed
- Crossref
- Google Scholar
- Felker G.M.
- O’Connor C.M.
- Braunwald E.
- Heart Failure Clinical Research Network Investigators
Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?. 2009; 2: 56-62View in Article- Scopus (229)
- PubMed
- Crossref
- Google Scholar
- Follath F.
- Yilmaz M.B.
- Delgado J.F.
- et al.
Clinical presentation, management and outcomes in the acute heart failure global survey of standard treatment (ALARM-HF). 2011; 37: 619-626View in Article- Scopus (181)
- PubMed
- Crossref
- Google Scholar
- Singh A.
- Laribi S.
- Teerlink J.R.
- et al.
Agents with vasodilator properties in acute heart failure. 2017; 38: 317-325View in Article- Scopus (37)
- PubMed
- Crossref
- Google Scholar
- Optimizing hypertensive acute heart failure management with afterload reduction. 2018; 20: 9View in Article
- Scopus (9)
- PubMed
- Crossref
- Google Scholar
- The role of nitroglycerin and other nitrogen oxides in cardiovascular therapeutics. 2017; 70: 2393-2410View in Article
- Brown B.G.
- Bolson E.
- Petersen R.B.
- et al.
The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. 1981; 64: 1089-1097View in Article- Elkayam U.
- Kulick D.
- McIntosh N.
- et al.
Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure. 1987; 76: 577-584View in Article- Scopus (194)
- PubMed
- Crossref
- Google Scholar
- Dupuis J.
- Lalonde G.
- Lemieux R.
- et al.
Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. 1990; 16: 923-931View in Article- Mullens W.
- Abrahams Z.
- Francis G.S.
- et al.
Sodium nitroprusside for advanced low-output heart failure. 2008; 52: 200-207View in Article- Scopus (145)
- PubMed
- Crossref
- Google Scholar
- Management of acute decompensated heart failure.in: Mann D.L. Felker G.M. Heart failure: a companion to Braunwald’s heart disease. 3rd edition. Elsevier, Philadelphia2016: 514-534View in Article
- Hypertensive crisis.in: Dimarco J. Cardiology. 3rd edition. Elsevier Ltd, Philadelphia2010: 607-618View in Article
- Wakai A.
- McCabe A.
- Kidney R.
- et al.
Nitrates for acute heart failure syndromes. 2013; (CD005151)View in Article- Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)
Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. 2002; 287: 1531-1540View in Article- Beltrame J.F.
- Zeitz C.J.
- Unger S.A.
- et al.
Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema. 1998; 4: 271-279View in Article- Scopus (52)
- PubMed
- Abstract
- Full Text PDF
- Google Scholar
- Levy P.
- Compton S.
- Welch R.
- et al.
Treatment of severe decompensated heart failure with high-dose intravenous nitroglycerin: a feasibility and outcome analysis. 2007; 50: 144-152View in Article- Scopus (106)
- PubMed
- Abstract
- Full Text
- Full Text PDF
- Google Scholar
- Wilson S.S.
- Kwiatkowski G.M.
- Millis S.R.
- et al.
Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure. 2017; 35: 126-131View in Article- Scopus (25)
- PubMed
- Abstract
- Full Text
- Full Text PDF
- Google Scholar
- Cotter G.
- Metzkor E.
- Kaluski E.
- et al.
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. 1998; 351: 389-393View in Article- Scopus (445)
- PubMed
- Abstract
- Full Text
- Full Text PDF
- Google Scholar
- Colucci W.S.
- Elkayam U.
- Horton D.P.
- et al.
Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. 2000; 343: 246-253View in Article- Scopus (857)
- PubMed
- Crossref
- Google Scholar
- O’Connor C.M.
- Starling R.C.
- Hernandez A.F.
- et al.
Effect of nesiritide in patients with acute decompensated heart failure. 2011; 365: 32-43View in Article- Scopus (992)
- PubMed
- Crossref
- Google Scholar
- Grossman E.
- Ironi A.N.
- Messerli F.H.
Comparative tolerability profile of hypertensive crisis treatments. 1998; 19: 99-122View in Article- Ayaz S.I.
- Sharkey C.M.
- Kwiatkowski G.M.
- et al.
Intravenous enalaprilat for treatment of acute hypertensive heart failure in the emergency department. 2016; 9: 28View in Article- Annane D.
- Bellissant E.
- Pussard E.
- et al.
Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema. 1996; 94: 1316-1324View in Article- Scopus (60)
- PubMed
- Crossref
- Google Scholar
- Anker S.D.
- Ponikowski P.
- Mitrovic V.
- et al.
Ularitide for the treatment of acute decompensated heart failure: from preclinical to clinical studies. 2015; 36: 715-723View in Article- Scopus (59)
- PubMed
- Crossref
- Google Scholar
- Mitrovic V.
- Lüss H.
- Nitsche K.
- et al.
Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo-controlled, ascending-dose trial. 2005; 150: 1239View in Article- Scopus (83)
- Crossref
- Google Scholar
- Mitrovic V.
- Seferovic P.M.
- Simeunovic D.
- et al.
Haemodynamic and clinical effects of ularitide in decompensated heart failure. 2006; 27: 2823-2832View in Article- Scopus (130)
- PubMed
- Crossref
- Google Scholar
- Kentsch M.
- Ludwig D.
- Drummer C.
- et al.
Haemodynamic and renal effects of urodilatin bolus injections in patients with congestive heart failure. 1992; 22: 662-669View in Article- Packer M.
- O’Connor C.
- McMurray J.J.V.
- et al.
Effect of ularitide on cardiovascular mortality in acute heart failure. 2017; 376: 1956-1964View in Article- Scopus (208)
- PubMed
- Crossref
- Google Scholar
- Relaxin receptors and nitric oxide synthases: search for the missing link. 2003; 1: 5View in Article
- Dschietzig T.
- Bartsch C.
- Richter C.
- et al.
Relaxin, a pregnancy hormone, is a functional endothelin-1 antagonist: attenuation of endothelin-1-mediated vasoconstriction by stimulation of endothelin type-B receptor expression via ERK-1/2 and nuclear factor-kappaB. 2003; 92: 32-40View in Article- Teichman S.L.
- Unemori E.
- Teerlink J.R.
- et al.
Relaxin: review of biology and potential role in treating heart failure. 2010; 7: 75-82View in Article- Scopus (110)
- PubMed
- Crossref
- Google Scholar
- Teerlink J.R.
- Metra M.
- Felker G.M.
- et al.
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. 2009; 373: 1429-1439View in Article- Scopus (355)
- PubMed
- Abstract
- Full Text
- Full Text PDF
- Google Scholar
- Teerlink J.R.
- Cotter G.
- Davison B.A.
- et al.
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. 2013; 381: 29-39View in Article- Scopus (742)
- PubMed
- Abstract
- Full Text
- Full Text PDF
- Google Scholar
- Efficacy, safety and tolerability of serelaxin when added to standard therapy in AHF (RELAX-AHF-2). (Available at:)https://clinicaltrials.gov/ct2/show/NCT01870778 (Accessed February 3, 2019)View in Article
- Aroney C.N.
- Semigran M.J.
- Dec G.W.
- et al.
Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. 1989; 14: 1331-1338View in Article- Packer M.
- Lee W.H.
- Medina N.
- et al.
Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunction. 1987; 10: 1303-1311View in Article- Kieler-Jensen N.
- Jolin-Mellgård A.
- Nordlander M.
- et al.
Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery. 2000; 44: 186-193View in Article- Scopus (57)
- PubMed
- Crossref
- Google Scholar
- Peacock F.
- Varon J.
- Ebrahimi R.
- et al.
Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis. 2010; 16: 55-59View in Article- Scopus (19)
- PubMed
- Crossref
- Google Scholar
- Peacock W.F.
- Chandra A.
- Char D.
- et al.
Clevidipine in acute heart failure: results of the a study of blood pressure control in acute heart failure-a pilot study (PRONTO). 2014; 167: 529-536View in Article- Scopus (64)
- PubMed
- Crossref
- Google Scholar
- Stasch J.P.
- Schmidt P.
- Alonso-Alija C.
- et al.
NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. 2002; 136: 773-783View in Article- Scopus (265)
- PubMed
- Crossref
- Google Scholar
- Lapp H.
- Mitrovic V.
- Franz N.
- et al.
Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure. 2009; 119: 2781-2788View in Article- Scopus (111)
- PubMed
- Crossref
- Google Scholar
- Erdmann E.
- Semigran M.J.
- Nieminen M.S.
- et al.
Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure. 2013; 34: 57-67View in Article- Gheorghiade M.
- Greene S.J.
- Filippatos G.
- et al.
Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes. 2012; 14: 1056-1066View in Article- Pieske B.
- Maggioni A.P.
- Lam C.S.P.
- et al.
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study. 2017; 38: 1119-1127View in Article- Scopus (224)
- PubMed
- Crossref
- Google Scholar
Read more Proceedings of the 6th World Symposium on Pulmonary Hypertension
References
